Liftaz 500mg/250mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Liftaz 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration requires strict adherence to a healthcare provider's instructions; missed doses should be avoided. Complete the prescribed course, even with symptom improvement; premature cessation may compromise efficacy. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all medications and pre-existing conditions before commencing treatment. Pregnant or lactating individuals require prior physician approval. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote recovery. Your doctor might order tests to monitor the treatment's impact.
Primary Ingredients of Liftaz 500mg/250mg Injection
No information provided. A rewritten text cannot be provided.
Uses of Liftaz 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Liftaz 500mg/250mg Injection:
Administering this medication will be handled by your physician or their designated nurse; please refrain from self-medicating.
Common Side effects of Liftaz 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Liftaz 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Liftaz 500mg/250mg Injection works:
Ceftriaxone/Sulbactam 500mg/250mg Injection (Liftaz) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Liftaz 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Liftaz, 500mg/250mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human subjects, however, remain scarce.
Breast feedingCAUTION
Administering Liftaz 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Liftaz 500mg/250mg Injection may induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Liftaz 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Liftaz 500mg/250mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dosage of Liftaz 500mg/250mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Liftaz 500mg/250mg Injection :
Should you inadvertently skip a scheduled dose of Liftaz 500mg/250mg Injection, seek medical advice from your physician.
Facts to Know About Liftaz 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently